ArticlePloS one2020

Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.